Stephens analyst Sudan Loganathan downgraded Centessa Pharmaceuticals (NASDAQ: CNTA) from Overweight to Equal Weight.

For an analyst ratings summary and ratings history on Centessa Pharmaceuticals click here. For more ratings news on Centessa Pharmaceuticals click here.

Shares of Centessa Pharmaceuticals closed at $27.58 yesterday.